Dr Sheri Nixdorf

Field: Oncology and Carcinogenesis

Contact Details

Phone: 02 9382 6805
Fax: 93851510
Email: s.nixdorf@unsw.edu.au

Tabs

Main

University role:

Consultancies and Vendor Staff

Dr Sheri Nixdorf is an Associate Lecturer in the School of Women's and Children's Health, Faculty of Medicine, UNSW Australia. Dr Nixdorf's interests lie in elucidating the mechanisms of tumourigenesis and cancer cell metastasis in order to identify disease biomarkers, and inform the development and use of targeted therapies.

Dr Nixdorf enjoys teaching undergraduate and postgraduate students in the areas of Personalised Medicine, Cancer Sciences/Therapeutics, Research Methodologies and Ethics.

Society Memberships:
Translational Cancer Research Network (TCRN); The American Association of Cancer Research (AACR); European Association for Cancer Research (EACR); Australasian Metastasis Research Society; South West Sydney Cancer Advocacy Network (SWSCAN); Cancer Voices NSW; The Society for Neuro-Oncology; British Neuro-Oncology Society; Philosophy of Education Society of Australasia; Australasian Association of Bioethics and Health Law; American Association for the Advancement of Science (AAAS).

Qualifications:

BSc(Hons); PhD; GCULT - UNSW Australia.

History

Member for: 12 years 4 months

Research

Socio-economic Objective (SEO) tags:

Clinical Health (Organs, Diseases and Abnormal Conditions)

Teaching & Supervision

Teaching:

MOOC - Myths and Realities of Personalised Medicine: The Genetic Revolution via Future Learn (https://www.futurelearn.com/courses/personalised-medicine); GENM0295 - Personalised Medicine; PATH3208 - Cancer Sciences; PHAR9917 - Cancer Therapeutics, Ethics in Medicine- Phase 1.

Publications related to this Person

Journal articles

Zaman A; Rapkins R; Nixdorf S; Teo C; McDonald K, 2016, 'TMOD-14. ESTABLISHMENT AND MOLECULAR CHARACTERIZATION OF PATIENT DERIVED CELL LINES FROM LOW GRADE GLIOMA', Neuro-Oncology, vol. 18, pp. vi209 - vi210, http://dx.doi.org/10.1093/neuonc/now212.884

Decollogne S; Joshi S; Chung SA; Luk PP; Yeo RX; Nixdorf S; Fedier A; Heinzelmann-Schwarz V; Hogg PJ; Dilda PJ, 2015, 'Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells', Gynecologic Oncology, vol. 138, pp. 363 - 371, http://dx.doi.org/10.1016/j.ygyno.2015.06.018

Jacob F; Hitchins MP; Fedier A; Brennan K; Nixdorf S; Hacker NF; Ward R; Heinzelmann-Schwarz VA, 2014, 'Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells', BMC Molecular Biology, vol. 15, http://dx.doi.org/10.1186/1471-2199-15-24

Jacob F; Hitchins MP; Fedier A; Nixdorf S; Hacker NF; Ward R; Heinzelmann-Schwarz V, 2014, 'Reversal of Forssman synthetase gene hypermethylation by 5-aza-2'-deoxycytidine in A2780 ovarian cancer cells', Geburtshilfe und Frauenheilkunde, vol. 74, http://dx.doi.org/10.1055/s-0034-1388354

Anugraham M; Jacob F; Nixdorf S; Everest-Dass AV; Heinzelmann-Schwarz V; Packer NH, 2014, 'Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: Glycan structures reflect gene expression and DNA methylation status', Molecular and Cellular Proteomics, vol. 13, pp. 2213 - 2232, http://dx.doi.org/10.1074/mcp.M113.037085

Jacob F; Nixdorf S; Hacker NF; Heinzelmann-Schwarz VA, 2014, 'Reliable in vitro studies require appropriate ovarian cancer cell lines', Journal of Ovarian Research, vol. 7, pp. 60 - 60, http://dx.doi.org/10.1186/1757-2215-7-60

Heinzelmann-Schwarz VA; Nixdorf S; Valadan M; Diczbalis M; Olivier J; Otton G; Fedier A; Hacker NF; Scurry JP, 2014, 'A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker', International Journal of Molecular Medicine, vol. 33, pp. 784 - 794, http://dx.doi.org/10.3892/ijmm.2014.1659

Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V, 2014, 'The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer', Gynecologic Oncology, vol. 134, pp. 338 - 345, http://dx.doi.org/10.1016/j.ygyno.2014.06.004

Jacobs F; Guertler R; Nixdorf S; Fedier A; Hacker NF; Heinzelmann-Schwarz VA; Naim S, 2013, 'Careful Selection of Reference Genes Is Required for Reliable Performance of RT-qPCR in Human Normal and Cancer Cell Lines', PLoS One, vol. 8, pp. Art. no. e59180, http://dx.doi.org/10.1371/journal.pone.0059180

Ford CE; Jary E; Ma S; Nixdorf S; Heinzelmann-Schwarz V; Ward RL, 2012, 'SFRP4 modulates EMT, cell migration and downstream Wnt signalling in epithelial ovarian cancer.', CANCER RESEARCH, vol. 72, http://dx.doi.org/10.1158/1538-7445.AM2012-333

Jacob F; Ukegjini K; Nixdorf S; Ford CE; Olivier J; Caduff R; Scurry J; Guertler R; Hornung D; Mueller R; Fink D; Hacker NF; Heinzelmann-Schwarz VA, 2012, 'Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients', PLoS One, vol. 7, pp. Art no. e31885, http://dx.doi.org/10.1371/journal.pone.0031885

Loberg R; Neeley C; Adam-Day L; Fridman Y; St John L; Nixdorf S; Jackson P; Kalikin L; Pienta K, 2005, 'Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology', International Journal of Oncology, vol. 26, pp. 1699 - 1706

Nixdorf S; Grimm M; Loberg R; Marreiros A; Russell PJ; Pienta K; Jackson P, 2004, 'Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines', Cancer Letters, vol. 215, pp. 209 - 220, http://dx.doi.org/10.1016/j.canlet.2004.05.002

Downing S; Bumak CL; Nixdorf S; Ow KT; Russell PJ; Jackson P, 2003, 'Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumour metastasis', Molecular Carcinogenesis, vol. 38, pp. 130 - 140, http://dx.doi.org/10.1002/mc.10154

Conference Papers

Conference Posters

Chisholm OT; Gomes L; Thai T; Nixdorf S; Williams R; Clayphan A; Vigentini L; Zhang C; Zhao L; King M; Ford C, (ed.), 2016, 'Empowering Online Learners Using Assessment and Feedback', in UNSW Learning and Teaching Forum, UNSW, UNSW, presented at Towards 2025: Inspiring Learning, UNSW, 31 October 2016 - 31 October 2016

Conference Presentations

Nixdorf S; Chisholm OT; Gomes L; Ford C, 2016, 'Student Engagement in the Personalised Medicine MOOC: Does the Learning Platform Matter?', in Student Engagement in the Personalised Medicine MOOC: Does the Learning Platform Matter?, UNSW Medicine Learning and Teaching Forum, UNSW, Sydney, presented at UNSW Medicine Learning and Teaching Forum, UNSW, Sydney, 07 December 2016 - 07 December 2016

Chisholm O; Nixdorf S; Williams R; Ford C, 2014, 'Reflections on the development of an open online course', in Reflections on the development of an open online course, UNSW Medicine Learning and Teaching Forum 2014, UNSW Australia, presented at UNSW Medicine Learning and Teaching Forum 2014, UNSW Australia, 10 December 2014 - 10 December 2014, http://med.unsw.edu.au/annual-learning-and-teaching-forum

Downing S; Jackson P; Nixdorf S; Daja MM; Russell PJ, 2000, 'Prostate-specific mutations in p53 result in increased levels of PSA', in Proceedings of the American Association for Cancer Research, American Association Cancer Research, San Francisco, California USA, presented at 91st Annual Meeting of the AACR, San Francisco, California USA, 01 April 2000 - 05 April 2000